The Brigham Board Review in Endocrinology 2016 (Videos+PDFs)

The Brigham Board Review in Endocrinology 2016

Brigham and Women’s Hospital Board Review

Product Details

  • Oakstone Price: $1195.
  • Points to Download: 1200 Points
  • Format: 48 Video Files (.mp4 format) + 2 PDF files.
  • File Size: 8.65GB.
  • Download Link Below.

Download Link:

This post contains protected content. You must be logged in and have 1200 points to unlock it.


Description:

CME Board Review in Endocrinology

This CME program is a wide-ranging review of the essential topics in endocrinology. The Brigham Board Review in Endocrinology includes case-based lectures on topics like type 1 and type 2 diabetes, antidiabetic agents, diabetic emergencies, pituitary and hypothalamic disorders, adrenal disorders, etc. It will help you to:

  • Prepare for the American Board of Internal Medicine (ABIM) Endocrinology certification and recertification examinations
  • Demonstrate improved understanding of endocrine diseases
  • Correlate pathophysiology and pathobiology with clinical presentations
  • Evaluate the latest therapeutic strategies with risks and benefits
  • Attain the latest knowledge for management of diabetes, obesity, osteoporosis, menopausal symptoms, gender dysphoria, etc.
  • Apply new information to your daily practice, improving diagnostic accuracy and patient management

Expand Your Skills

A comprehensive board review, this learn-at-your-own-pace course in endocrinology provides a maximum of 33.25 AMA PRA Category 1 Credits ™ and 33.25 MOC points. Available online or via audio MP3 CDs, it provides access to unbiased, evidence-based content and case-based reviews so that you may expand your knowledge and incorporate the latest guidelines into your daily practice.

Accreditation

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Oakstone Publishing, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation

Oakstone Publishing, LLC designates this enduring material for a maximum of 33.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 33.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Date of Original Release: December 31, 2016
Credit Expiration Date: December 31, 2019
Contact Hours: 33.25

CME credit is obtained upon successful completion of a course evaluation and post-test.

Learning Objectives

After viewing this activity, participants should be able to affirm or modify their approach to patient management in the following areas:

  • Summarize and demonstrate increased overall knowledge of endocrine diseases
  • Identify and improve knowledge and clinical competence-based practice gaps in endocrinology
  • Correlate pathophysiology and pathobiologic principles with clinical presentations
  • Describe optimal therapeutic strategies and their risks and benefits
  • Apply the knowledge and strategies gained through participation in this activity to the board exam and daily practice

Intended Audience

This activity was designed for fellows/trainees and practicing endocrinologists and other professional affiliates (internists with an interest in endocrinology) who are preparing to take ABIM Board Review or Recertification Examinations or who seek CME in attempt to improve patient care.

Topics/Speaker:

Diabetes Mellitus and Hypoglycemia: Overview of Diabetes

  • Type 2 Diabetes Mellitus: Screening, Diagnosis and Prevention – Marie E. McDonnell, MD
  • Type 1 Diabetes Mellitus – Margo S. Hudson, MD

Diabetes Mellitus and Hypoglycemia: Management of Hyperglycemia

  • Lifestyle Modification in Diabetes Management – Marie E. McDonnell, MD
  • Antidiabetic Agents 1: Metformin, Sulfonylureas, Meglitinides and Thiazolidinediones – Amir M. Tirosh, MD, PhD
  • Antidiabetic Agents 2: GLP-1 and SGLT-2: New Approaches to Type 2 Diabetes – Margo S. Hudson, MD
  • Antidiabetic Agents 3: Insulin – Alexander Turchin, MD, MS
  • Selecting Antidiabetic Therapy – Marie E. McDonnell, MD
  • Assessing Glycemic Control in Type 2 Diabetes – Alexander Turchin, MD, MS
  • Inpatient Hyperglycemia: Evidence-Based Approaches and Treatment Strategies – Nadine E. Palermo, DO
  • Hyperglycemic Crisis: Diagnosis, Management and Transition of Care – Nadine E. Palermo, DO
  • Diabetes in Pregnancy – Marie E. McDonnell, MD

Diabetes Mellitus and Hypoglycemia: Chronic Complications of Diabetes

  • Cardiovascular Risk Reduction in Diabetes – Bindu Chamarthi, MD, MMSc
  • Microvascular and Dermatologic Complications of Diabetes – Margo S. Hudson, MD

Lipids, Obesity and Nutrition

  • Evaluation and Management of Obesity – Florencia Halperin, MD
  • Assessment and Treatment of Dyslipidemia – Jorge Plutzky, MD

Thyroid Disorders

  • Hypothyroidism – Trevor E. Angell, MD
  • Hyperthyroidism and Thyroiditis – Matthew I. Kim, MD
  • Thyroid Nodules – Ellen Marqusee, MD
  • Improving Thyroid Nodule Care with Molecular Diagnostics – Preoperative Assessment – Erik K. Alexander, MD
  • Thyroid Cancers – Trevor E. Angell, MD

Calcium and Bone Disorders

  • Evaluation of the Patient with Low Bone Density – Sharon H. Chou, MD
  • Treatment of Osteoporosis – Sharon H. Chou, MD
  • Hypercalcemia – J. Carl Pallais, MD
  • Hypocalcemia – J. Carl Pallais, MD
  • Topics in Metabolic Bone Disease – Eva S. Liu, MD
  • Calcium and Bone Cases for the Boards – Carolyn B. Becker, MD

Pituitary and Hypothalamic Disorders

  • Anterior and Posterior Pituitary Insufficiency – Le Min, MD, PhD
  • Pituitary Masses – Ursula B. Kaiser, MD
  • Prolactin and Growth Hormone Excess – Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc
  • Neuroendocrine Cases for the Boards – Ursula B. Kaiser, MD

Adrenal Disorders

  • Primary and Secondary Adrenal Insufficiency – Jonathan S. Williams, MD, MMSc
  • Diagnosis and Treatment of Cushing’s Syndrome – Gail K. Adler, MD, PhD
  • Primary Hypertension – Naomi D. Fisher, MD
  • Endocrine Hypertension – Naomi D. Fisher, MD
  • Adrenal Nodules and Cancer – Anand Vaidya, MD, MMSc
  • Update on Pheochromocytomas and Paragangliomas – Anand Vaidya, MD, MMSc
  • Adrenal Cases for the Boards – Anand Vaidya, MD, MMSc

Reproductive Endocrinology

  • Evaluation of the Patient with Menstrual Irregularities – Maria A. Yialamas, MD
  • Management of Menopausal Symptoms – Ole-Petter R. Hamnvik MB, BCh, BAO, MMSc
  • Contraception Overview and Use in Women with Endocrine Disease – Caryn R. Dutton, MD
  • Polycystic Ovarian Syndrome and Approach to Female Androgen Excess Disorders – Grace Huang, MD
  • Infertility and Assisted Reproduction – Janis H. Fox, MD

Male Reproduction

  • Erectile and Ejaculatory Disorders – Michael P. O’Leary, MD
  • Male Reproductive Endocrine Cases for the Boards – J. Carl Pallais, MD

Genetics in Endocrinology

  • Hereditary Syndromes in Endocrinology: Genetics and Management – Adi Barlev-Ehrenberg, MD, MS
  • Gender Dysphoria and Medical Management of the Transgender Patient – Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc
  • Hypoglycemia in Non-Diabetic Patients: Diagnosis and Management – Rajesh K. Garg, MD
  • Carcinoid and Pancreatic Neuroendocrine Tumors – Ole-Petter R. Hamnvik, MB, BCh, BAO, MMSc

Written by 

Leave a Reply

Your email address will not be published. Required fields are marked *